Latest News Archive
Please select Category, Year, and then Month to display items
27 August 2019
|
Story Moeketsi Mogotsi
|
Photo Johan Roux
Katleho Lechoo, newly elected SRC President on the Bloemfontein Campus and Sonawible Dwaba, outgoing SRC President.
The University of the Free State’s Student Representative Council (SRC) elections took place on the Bloemfontein,
Qwaqwa, and
South campuses during August.
The following candidates were successfully elected as 2019/2020 SRC members on our three respective campuses.
BLOEMFONTEIN CAMPUS SRC:President:Katleho Lechoo
Deputy President:Agobakwe Mboweni
Secretary:Nothabo Zungu
Treasurer:Zandile Makalima
Policy and Transformation:Kamohelo Thakheli
Student Development and First-Generation Students:Thobeka Buti
Commuter Students:Karabo Mtsweni
Associations Student Council:Mandilakhe Magalakanqa
Student Organisations Council:Dieketseng Motaung
Academic Student Council:Lebofsa Malete
Day Residence Council:Gert Terblanche
Campus Residence Council:Tyrone Willard
Postgraduate Student Council:Mahlomola Khasemene
International Student Council:Simba Matem
Student Media and Dialogue Council:Karabo Masike
Universal Access and Social Justice Council:Micaula Jewell
Civic and Social Responsibility Council:Nthato Musa
Arts and Culture Council:Motshidisi Rasego
Sports Council:Sphumelele Dube
QWAQWA CAMPUS SRC:President:Xolani Sandile Sibiya
Deputy President:Thembinkosi Phenyane
Secretary General:Nelisiwe Bridget Masango
Treasurer:Ntandoyenkosi Khumalo
Policy and Transformation:Bongiwe Nakile Khumalo
Student Development and First-Generation Students:Thokozani Siphiwe Zuma
Commuter Students:Thabiso Celimpilo Masuku
Media and Publicity:Simphiwe Sinenhlanhla Dube
Associations and Religious Affairs Student Council: Sicelo Mathews Twala
Campus Residence Council: Thabo Abraham Motaung
Arts and Culture Council:Andile Saviour Maseko
Academics Council:Siyabonga Mpumelelo Mbambo
Sports Council: Tshepiso Fortune Tshabalala
Universal Access and Social Justice Council: Siphamandla Joseph Shabangu
Postgraduate Student Council:Thato Karabo Moloi
International Student Council:Mamokete Mokhatla
SOUTH CAMPUS SRC:President: Phehellang Ralejoe
Deputy President:Nokubonga Mangaliso
Secretary:Mpumelelo Ndzube
Treasurer:Sithembiso Khoza
Policy and Transformation:Casles Phasha
Commuter Students:Sthembele Kunene
Announcement of 2019/2020 SRC
Kathelo Leechoo, SRC President, address the crowd
First sitting of the newly elected SRC on the Bloemfontein Campys
First sitting of the newly elected SRC on the Bloemfontein Campys
Katleho Leechoo
SRC results were announced on Monday 26 August 2019
Pura Mgolombane, Dean of Student Affairs
The new Student Representative Council for the Bloemfontein Campus
UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08
The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.
The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.
The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.
“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.
“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.
According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.
The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.
According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.
The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.
Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004